A CRISPR response to pandemics?: Exploring the ethics of genetically engineering the human immune system.
EMBO reports, 22(3): e52319 PMID 33615649 DOI 10.15252/embr.202052319
Abstract
Ethical challenges should be addressed before gene editing is made available to improve the immune response against emerging viruses.